Neuromod Devices to double Irish headcount within next year
The medtech company, which specialises in neuromodulation devices indicated for the treatment of tinnitus, said it hopes to roll out its product in European countries such as France, Spain and the Netherlands
Neuromod, the Irish medical devices company, will increase its employee headcount at its Dublin office to 100 within the next year as it further develops its telemedicine offering.
The company, which produces a neuromodulation device for the treatment of tinnitus called Lenire, serves its Ireland and UK markets from its office in Dublin 8 and also offers telemedicine consultations for its patients where they can learn about the device and discuss having it fitted.
Dr Ross O’Neill, chief executive and founder of the company, told the Business Post that Neuromod will expand its telemedicine service to serve increased demand for remote services brought about by the pandemic.